Faculty

Institution

Unit

Venue

Kathryn Maurer

Gynecologic Oncologist and Assistant Professor Assistant Professor

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Kathryn Maurer is currently serving as an Obstetrics And Gynecology Gynecologic Oncologist and Assistant Professor Assistant Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kathryn Maurer

University of Utah

Gynecologic Oncologist and Assistant Professor Assistant Professor

You can click a keyword to filter the displayed items

gynecologic oncology gynecology oncology obstetrics and gynaecology endometrial cancer cancer research survival analysis cancer care surgical oncology obstetrics cancer treatment cancer management epidemiology health sciences cervical cancer cancer biology complex atypical hyperplasia endocrinology cancer imaging lymphoid neoplasia cancer risk positive lymph nodes medicine signal transduction family planning outcomes research death studies cancer cells urogynecology oncogenes endocrine oncology disparate impact cancer screening prognosis clinical endpoint clinical mycology hypersensitivity end-of-life care end-of-life issues gynecological surgery patient-centered outcomes postoperative consideration postoperative treatment radiation therapy therapy resistance clinical radiation oncology prospective cohort studies cohort studies same-day cervical preparation variable impact bariatric specialists mullerian origin neoadjuvant chemotherapy percent reduction advanced-stage cancer interval cytoreduction urinary injury placenta accreta spectrum surgical restaging early endometrial cancer gynecologic malignancies gynecologic cancers pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and Gynecology (2022)

Morgan A. ScaglioneAmanda A. AllshouseDana R. CanfieldHannah D. MclaughlinAnn M. BrunoIbrahim A. HammadD. Ware BranchKathryn A. MaurerRobert L. DoodMichelle P. DebbinkRobert M. SilverBrett D. Einerson

gynecologyurologyobstetrics and gynaecologyobstetricsmaternal healthurinary injuryplacenta accreta spectrum

Refusal of Surgery and Survival Outcomes in Endometrial Cancer. International Journal of Gynecological Cancer (2021)

Alli M StraubharMatthew W ParsonsSamual FrancisDavid GaffneyKathryn A Maurer

oncologysurgerysurvival outcomesendometrial cancergynecologic oncology

Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-Up. International Journal of Radiation Oncology*Biology*Physics (2021)

A C CasperM W ParsonsJ ChipmanL M BurtG SunejaK A MaurerD K Gaffney

oncologyradiation oncologyovarian cancerovarian cancer survivorscancer risksurvival analysissecondary malignanciesepidemiology

Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. American Journal of Clinical Oncology (2020)

Matthew W. ParsonsSamual FrancisKathryn A. MaurerJon GrantDavid K. Gaffney

oncologyradiation oncologyinferior survivalendometrial cancergynecologic oncology

Refusal of Surgery by Young Women (Age 41) With Endometrial Cancer Does Not Impact Overall Survival. Gynecologic Oncology (2020)

A. StraubharM. ParsonsS. FrancisD. GaffneyK. Maurer

young womensurgeryoverall survivalendometrial cancerwomen's healthgynecologic oncology

216 the Deleterious Survival Impact of Positive Lymph Nodes in Cervical Cancer: Implications of the New Figo Staging System. (2019)

A TorgesonD GaffneyK McComasK MaurerL Burt

gynecologygynecologic cancerscancer biologypositive lymph nodesoncologycancer researchcancer carecancer treatmentcancer riskdeleterious survival impactlymphoid neoplasiaimmunologysurvival analysisgynecologic oncologysurgical oncologycancer imagingcancer cellscancer managementcervical cancerpathology

Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway With Several Open Questions. Hormones and Cancer (2019)

Adriana C. RodriguezZannel BlanchardKathryn A. MaurerJason Gertz

gynecologymedicineoncologyendocrinologycancer researchendometrial cancerendocrine oncologysignal transductionhealth sciencesgynecologic oncology

Lvsi Positive and Nx in Early Endometrial Cancer: Surgical Restaging (and No Further Treatment If N0), or Adjuvant Ert?. Gynecologic Oncology (2019)

Katherine L. HarrisKathryn A. MaurerElke JarboeTheresa L. WernerDavid Gaffney

gynecologysurgical restagingearly endometrial cancergynecologic oncology

Mind Over Matter: Depression and Anxiety Are Common in Endometrial Cancer Survivors but Not Associated With Poorer Weight Loss Outcomes in a Prospective Observational Cohort. Gynecologic Oncology (2019)

E.V. ConnorK. MaurerK.R. CooperP.R. SchauerP.G. RoseC.M. MichenerA.M. Jernigan

mental healthanxiety disordersdepressionprospective observational cohortpsychologyendometrial cancer survivorsgynecologic oncology

Ovarian Remnant Syndrome in an Aromatase Inhibitor‐Treated Patient With Brca2 Mutation Following Bilateral Oophorectomy. The Breast Journal (2019)

Mei WeiKathryn A. MaurerN. Lynn Henry

urologygeneticssurgeryovarian cancerbilateral oophorectomyanatomyovarian remnant syndrome

1
2
3
10 / page

Kathryn Maurer

Gynecologic Oncologist and Assistant Professor Assistant Professor

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Kathryn Maurer is currently serving as an Obstetrics And Gynecology Gynecologic Oncologist and Assistant Professor Assistant Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kathryn Maurer

University of Utah

Gynecologic Oncologist and Assistant Professor Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and Gynecology (2022)

gynecologyurologyobstetrics and gynaecologyobstetricsmaternal healthurinary injuryplacenta accreta spectrum

Refusal of Surgery and Survival Outcomes in Endometrial Cancer. International Journal of Gynecological Cancer (2021)

Alli M StraubharMatthew W ParsonsSamual FrancisDavid GaffneyKathryn A Maurer

oncologysurgerysurvival outcomesendometrial cancergynecologic oncology

Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-Up. International Journal of Radiation Oncology*Biology*Physics (2021)

A C CasperM W ParsonsJ ChipmanL M BurtG SunejaK A MaurerD K Gaffney

oncologyradiation oncologyovarian cancerovarian cancer survivorscancer risksurvival analysissecondary malignanciesepidemiology

Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. American Journal of Clinical Oncology (2020)

Matthew W. ParsonsSamual FrancisKathryn A. MaurerJon GrantDavid K. Gaffney

oncologyradiation oncologyinferior survivalendometrial cancergynecologic oncology

Refusal of Surgery by Young Women (Age 41) With Endometrial Cancer Does Not Impact Overall Survival. Gynecologic Oncology (2020)

A. StraubharM. ParsonsS. FrancisD. GaffneyK. Maurer

young womensurgeryoverall survivalendometrial cancerwomen's healthgynecologic oncology

216 the Deleterious Survival Impact of Positive Lymph Nodes in Cervical Cancer: Implications of the New Figo Staging System. (2019)

A TorgesonD GaffneyK McComasK MaurerL Burt

Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway With Several Open Questions. Hormones and Cancer (2019)

Adriana C. RodriguezZannel BlanchardKathryn A. MaurerJason Gertz

gynecologymedicineoncologyendocrinologycancer researchendometrial cancerendocrine oncologysignal transductionhealth sciencesgynecologic oncology

Lvsi Positive and Nx in Early Endometrial Cancer: Surgical Restaging (and No Further Treatment If N0), or Adjuvant Ert?. Gynecologic Oncology (2019)

Katherine L. HarrisKathryn A. MaurerElke JarboeTheresa L. WernerDavid Gaffney

gynecologysurgical restagingearly endometrial cancergynecologic oncology

E.V. ConnorK. MaurerK.R. CooperP.R. SchauerP.G. RoseC.M. MichenerA.M. Jernigan

mental healthanxiety disordersdepressionprospective observational cohortpsychologyendometrial cancer survivorsgynecologic oncology

Ovarian Remnant Syndrome in an Aromatase Inhibitor‐Treated Patient With Brca2 Mutation Following Bilateral Oophorectomy. The Breast Journal (2019)

Mei WeiKathryn A. MaurerN. Lynn Henry

urologygeneticssurgeryovarian cancerbilateral oophorectomyanatomyovarian remnant syndrome

1
2
3
10 / page

Similar Faculty Members

Emma Barber

Institution

Northwestern University

gynecologic oncology

gynecology

Theresa Werner

Institution

University of Utah

ovarian cancer

pathology

Steven Plaxe

Institution

University of California, San Diego

oncology

gynecologic oncology

Sophia George

Institution

University of Miami

public health ethic

epidemiology

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Groesbeck Parham

Institution

University of North Carolina at Chapel Hill

oncology

public health

Rebecca Arend

Institution

University of Alabama at Birmingham

ovarian cancer

pathology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Ashley Felix

Institution

Ohio State University

cancer disparities

molecular epidemiology

Similar Faculty Members

Emma Barber

Institution

Northwestern University

gynecologic oncology

gynecology

Theresa Werner

Institution

University of Utah

ovarian cancer

pathology

Steven Plaxe

Institution

University of California, San Diego

oncology

gynecologic oncology

Sophia George

Institution

University of Miami

public health ethic

epidemiology

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Groesbeck Parham

Institution

University of North Carolina at Chapel Hill

oncology

public health

Rebecca Arend

Institution

University of Alabama at Birmingham

ovarian cancer

pathology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Ashley Felix

Institution

Ohio State University

cancer disparities

molecular epidemiology